Chemotherapy Drug Articles & Analysis
17 news found
Combined with nanotechnology, "smart" drugs can actively target tumors by binding to corresponding receptors on tumor cells through interactions with phenotype-specific ligands conjugated to the delivery vehicle. ...
The end goals are to determine whether this targeted method of delivering chemotherapy can extend survival while also improving quality of life. Although pancreatic cancer treatment has improved, pancreatic cancer patients continue to have poor outcomes – partially due to the tissue surrounding the tumor hampering intravenously delivered chemotherapy ...
ByxCures
Drug therapy is one of the major modalities for cancer treatment. However, drug resistance may reveal whether it is chemotherapy drugs, targeted drugs, or immunotherapy drugs. ...
” About SEngine Precision Medicine SEngine's mission is to deliver innovative precise targeted oncology drugs to individual patients by combining functional precision medicine and drug discovery. ...
Other symptoms of GBM may include any of the following: Persistent headaches Double or blurred vision Vomiting Loss of appetite New onset of seizures Speech difficulty of gradual onset Changes in mood and personality Changes in ability to think and learn Survival Rates for Glioblastoma The average survival rate following a diagnosis of glioblastoma, is less than two years; however, ...
Patients at Higher Risk of Wound Infections Some urgent care patients may have underlying conditions that could increase their risk of wound infections either due to the condition itself or the drugs used to treat it. Some examples include: Patients with diabetes. ...
KLS-13019 is the Company’s leading candidate to treat chemotherapy-induced peripheral neuropathy (CIPN), a disorder which currently has no FDA-approved drugs for treatment. ...
Ascelia Pharma AB (publ) (ticker: ACE) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for the upcoming global Phase 2 clinical study in gastric cancer with the daily oral chemotherapy candidate drug Oncoral. ...
Adding to the equation is the off-label use of opioids and gabapentinoids for chronic and neuropathic pain as a result of the unmet medical need and no FDA approved non-opioid drug to treat chronic and neuropathic pain, specifically Chemotherapy-induced peripheral neuropathy (CIPN). “With this generous support from the NIH, the hope of an effective ...
HER2 mutations are present in about 4 percent of patients with NSCLC, yet there is currently no targeted therapy approved by the U.S. Food & Drug Administration (FDA) for patients with HER2-mutated NSCLC.1 HTI recently released results from a phase 2 clinical trial demonstrating that pyrotinib showed promising antitumor activity in patients with HER2-mutant advanced NSCLC who ...
Daily online exclusives cover late breaking oncology news, safe handling and administration of chemotherapy drugs, side effect management, and new developments in specific cancers. ...
Additionally, these organic materials have the potential to load different drugs, including chemotherapeutic agents, for transarterial chemoembolization (TACE) procedures. ...
Radiation may be combined with chemotherapy. For people who can’t undergo surgery, radiation therapy and chemotherapy may be used as a primary treatment. Chemotherapy uses drugs to kill cancer cells. Types of chemotherapy include: Circular wafers are placed in your brain during surgery. As they slowly ...
A current or previous smoking habit, chronic lung disease, age (usually 50 years or older), and the use of certain rheumatoid arthritis and chemotherapy drugs can increase the risk of contracting Legionnaires’ disease. ...
A current or previous smoking habit, chronic lung disease, age (usually 50 years or older), and the use of certain rheumatoid arthritis and chemotherapy drugs can increase the risk of contracting Legionnaires’ disease. ...
Ruoyi Jiang, a senior at Ward Melville High School in East Setauket, New York, won the US$100,000 scholarship in the individual category for research on chemotherapy drug resistance. Sean Karson, a senior at Trinity Preparatory High School in Winter Park, Florida; Dan Liu, a junior at the Liberal Arts and Science Academy High School in Austin, Texas; and Kevin ...
Ruoyi Jiang, a senior at Ward Melville High School in East Setauket, New York, won the $100,000 scholarship in the individual category for research on chemotherapy drug resistance. Sean Karson, a senior at Trinity Preparatory High School in Winter Park, Florida; Dan Liu, a junior at the Liberal Arts and Science Academy High School in Austin, Texas; and Kevin ...